Small Stocks, Big Money

Calidi Biotherapeutics (NYSE American:CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s o...

Alliance Entertainment is the global leader in physical media distribution, acting as the crucial gateway between major content producers and retailers. The company partners with nearly every major film studio, music label, and video game maker, including Disney, Sony, Universal, Warner Bros., Universal Music, Sony Music, Warner Music, Microsoft, and Nintendo, to distribute their products to retai...

Nova Minerals Limited is a Gold, Antimony and Critical Minerals exploration and development company focused on advancing the Estelle Project, comprised of 514 km 2 of State of Alaska mining claims, which contains multiple mining complexes across a 35 km long mineralized corridor of over 20 advanced Gold and Antimony prospects, including two already defined multi-million ounce resources, and severa...

Tracking the MUSQ Global Music Industry Index (MUSQIX), the MUSQ Global Music Industry ETF (NYSE: MUSQ) includes publicly traded companies with core interests in music streaming, content and distribution, live events, satellite and broadcast radio, and music equipment and technology. RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or...

ASP Isotopes harnesses two decades of research and development to produce a broad range of isotopes, serving the expanding needs of nuclear medicine and green nuclear energy sectors. The Company's cutting-edge technology positions it to meet critical global demands heightened by recent geopolitical dynamics. With cold commissioning completed at its first plant and several strategic off-take agreem...

OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of DED and NCP, with ordinary shares listed for trading on the NASDAQ Capital Market. OKYO is focused on the discovery and development of novel molecules to treat inflammatory DED and ocular pain. In addition to the recently completed Phase 2 DED trial, OKYO also has p...

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The Company's primary focus is on its Specialized BioTherapeutics business segment, which is responsible for the development of HyBryte™ (synthetic hypericin), a novel photodynamic therapy utilizing safe visible light for the treatment...

OS Therapies (OSTX), a clinical stage biopharmaceutical company, is at the forefront of developing innovative treatments for Osteosarcoma (OS), breast cancer and other solid tumors. With a dedicated focus on addressing the unmet need for new cancer treatments in children and young adults, the company is making significant strides in tackling the complexities of OS, a rare but aggressive bone cance...

American Resources Corp. (NASDAQ: AREC) is a next-generation, environmentally and socially responsible supplier of high-quality raw materials to the new infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recyc...

GreenPower Motor Company is advancing the adoption of electric vehicles (EVs) by making all-electric buses and trucks affordable, durable and easy to deploy. GreenPower offers commercial vehicles for the movement of goods and people that are built from the ground up to be all-electric and are never converted. This “clean sheet” design ensures a safe, sustainable and sensible form of transportation...

Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believ...

Biotricity is transforming the healthcare market by bridging the gap in remote monitoring and chronic care management with a focus on cardiology. Physicians and patients trust Biotricity's unparalleled standard for preventive and personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the me...

bioAffinity Technologies, Inc. (NASDAQ: BIAF) addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. The Company’s first product, CyPath ® Lung , is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath ® Lung is marketed as a Laboratory Developed T...

In this exclusive interview, we sit down with the CEO of Alta Global Group (MMA) to uncover how they're transforming the world of MMA training. Discover their innovative strategies to engage 640 million MMA fans worldwide. Learn about their unique business model, partnerships with legends like Conor McGregor, and their vision for the future of mixed martial arts training. Topics Covered: Overview...

Can-Fite BioPharma is an advanced clinical stage drug development company with a platform of oral drugs designed to address multi-billion-dollar markets in the treatment of oncology and inflammatory diseases. The Company has 2 drug candidates in advanced stages of development, Piclidenoson for the treatment of psoriasis and Namodenoson for the treatment of advanced liver cancer. For each of the dr...

BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI. BioVie is poised for significant catalysts in 2023, including data read out from its Alzheimer’s Phase 3 trial...

1606 Corp. (OTC: CBDW) stands at the forefront of technological innovation in the online CBD industry. With a clear mission to revolutionize customer service in the digital marketplace, 1606 Corp. leverages state-of-the-art artificial intelligence (AI) solutions to address the significant challenges faced by consumers in the online CBD sector. Recognizing the unique needs of each business, 1606 Co...

Spectaire Holdings (Nasdaq: SPEC) represents a pioneering leap in environmental technology with its flagship AireCore system, a game-changer in emissions measurement and management. This innovative system, which includes a cutting-edge emissions measurement device, encrypted cloud storage, and intuitive desktop/mobile applications, offers a comprehensive solution for tracking and reducing carbon f...

Genetic Technologies is executing a B2B commercialization strategy for its flagship geneType multi-risk test covering breast cancer, colorectal cancer, prostate cancer, ovarian cancer, coronary artery disease and Type-2 diabetes, a first-in-class test that can predict a person’s risk in up to 70% of annual mortalities and morbidities before onset. The Multi-Risk test, along with integration of rec...

LOBO EV presents an attractive value proposition underpinned by its strategic growth initiatives and solid performance across key segments. With an established track record and a focus on becoming an OEM and ODM leader in the intelligent urban tricycles and off-highway four-wheeled electric vehicles (EVs) market over the next decade, LOBO EV is poised for significant growth. The Company is executi...

Enlivex presents a compelling investment opportunity in the biopharmaceutical sector with its innovative approach to treating life-threatening and debilitating conditions through macrophage reprogramming. The company's leading product, Allocetra™, is a groundbreaking, off-the-shelf cost-effective cell therapy platform designed to reset the body's immune cells (macrophages) to their optimal functio...

Biotricity is revolutionizing cardiac care with its cutting-edge remote diagnostic and monitoring solutions that cater to a $35 billion total addressable market opportunity. By integrating advanced hardware and proprietary software, Biotricity has established a new paradigm in cardiac care. The Company’s robust technology platform and product ecosystem, featuring FDA-cleared smart cardiac monitors...

Lytus Technologies, a dynamic platform services company with a robust presence across India, boasts over four million active users, leveraging its strategic business model focused on the distribution of linear content streaming/telecasting services and the development of cutting-edge technology products, including telemedicine. With a subscriber base rooted in more than one million connections, Ly...

Biotricity is a pioneering medical technology company delivering a full suite of remote diagnostic and remote patient monitoring hardware solutions which integrate with powerful and proprietary software solutions to deliver state-of-the-art cardiac care to patients. Leveraging a technology-as-aservice model, our innovative product portfolio, which includes our FDAcleared Bioflux® and Biotres devic...

Xcel Brands is a pioneering force in the convergence of shopping, entertainment, and social media and expects to generate $18 million in top-line royalty revenue in 2024. Based on the recent sale of 70% interest in its Isaac Mizrahi brand, which sold for six times royalty revenue, Xcel is trading for a greater than 75% discount to its intrinsic value, presenting tremendous potential upside for inv...